Post-exposure prophylaxis (PEP) is a medicine that helps lower your chances of getting HIV. You take it to stop the virus after you might have been exposed through sex or drug use. It's important to start PEP within 72 hours of possible exposure to HIV for it to work; the sooner you...
的HIV感染状态暴露事件的时间和类型可能的HIV暴露频率评估STIs(性传播感染)的可能性——通过注射或针刺传播的感染(如乙型肝炎或丙型肝炎病毒)女性需评估怀孕状态CentersforDiseaseControlandPrevention,U.S.DepartmentofHealthandHumanServices.UpdatedGuidelinesforAntiretroviralPostexposureProphylaxisAfterSexual,InjectionDrugUse,...
HIV/AIDSNon-occupational post-exposure prophylaxisChinaDrug users had low nPEP awareness and only about half participants reported willingness to use nPEP. It is essential to promote nPEP education campaigns among drug users, especially for elders, women and those with lower education level. ...
Or maybe you’re one of the relatively small number of people whose HIV treatment stops being able to fully keep the virus at bay, usually because of drug resistance. Regardless of the reasons, if your viral load is not undetectable and you’re having sex, it’s worth considering other fo...
2 PepsiCo Annual Report 2023 Pos•it iPvoesCithivoeicCehso: ices: • Continuing to transform our portfolio with new goals to further reduce sodium and deliver 145 billion portions of diverse ingredients such as legumes, whole grains, plant-based proteins, fruits, vegetables, and ...
The emergence of peptides as therapeutic drugs for the inhibition of HIV-1. AIDS Rev. 2007;9(4):208–17. PubMed Google Scholar Rapsch K, Bier FF, von Nickisch-Rosenegk M. Rational design of artificial beta-strand-forming antimicrobial peptides with biocompatible properties. Mol Pharm. ...
in a linear form. The enhanced metabolic stability should allow diminished doses at longer intervals. The restricted conformation should improve the drug selectivity, thereby potentially preventing side-effects. All of these properties are desirable in conjunction with the quest for new drug candidates....
Raltegravir-based HIV postexposure prophylaxis (PEP) in a real-life clinical setting: fewer drug–drug interactions (DDIs) with improved adherence and tolerabilityPOSTEXPOSURE PROPHYLAXIS (HIV)PREVENTIONANTIRETROVIRAL THERAPYCOMPLIANCEThe choice of preferred regimens for human immunodeficiency virus post...